These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Regression of recurrent membranoproliferative glomerulonephritis type II in a transplanted kidney after plasmapheresis therapy. Oberkircher OR; Enama M; West JC; Campbell P; Moran J Transplant Proc; 1988 Feb; 20(1 Suppl 1):418-23. PubMed ID: 2964750 [No Abstract] [Full Text] [Related]
4. Treatment and clinical outcome of glomerulonephritis in the elderly. Donadio JV Contrib Nephrol; 1993; 105():49-57. PubMed ID: 8252871 [No Abstract] [Full Text] [Related]
14. [Bases of antilymphocytic globulin and its therapeutic possibilities]. Brendel W Arzneimittelforschung; 1970 Feb; 20(2):191-7. PubMed ID: 4191782 [No Abstract] [Full Text] [Related]
15. [Therapeutic plasma exchange: indications and results]. Roujeau JC; Quaranta JF; Guillevin L; Cassuto JP; Chalopin JM; Gajdos P; Sobel A; Rifle G Ann Med Interne (Paris); 1984; 135(4):308-27. PubMed ID: 6236729 [No Abstract] [Full Text] [Related]
16. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis]. Ito C; Ando Y; Akimoto T; Kusano E; Asano Y Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918 [TBL] [Abstract][Full Text] [Related]
17. [Immunopathological bases of the treatment of glomerulonephritis]. Vercellone A; Segoloni G; Stratta P; Coppo R; Triolo G; Messina M Minerva Med; 1978 Aug; 69(38):2611-24. PubMed ID: 152419 [No Abstract] [Full Text] [Related]
20. Immune complex type crescentic glomerulonephritis and ANCA-positivity in a nine-year-old girl. Soylu A; Kavukçu S; Turgut CS; Türkmen M; Sarioğlu S Turk J Pediatr; 2002; 44(2):172-5. PubMed ID: 12026211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]